Bristol-Myers Squibb Australia Pty Ltd is a foreign-owned, private company, deriving revenue from the provision of pharmaceutical products. The company employs approximately 240 staff, operates in Australia, and is administered from its head office in Mulgrave, Victoria.

Bristol-Myers Squibb Australia Pty Ltd is a wholly owned subsidiary of the US-based prescription pharmaceuticals manufacturer, Bristol-Myers Squibb Company.

Bristol-Myers Squibb Australia Pty Ltd imports, distributes and sells pharmaceutical products. The company provides the following products:

  • Azactam
  • Baraclude
  • Ceenu
  • Daklinza
  • Eliquis
  • Etopophos
  • Evotaz
  • Hydrea
  • Monopril
  • Opdivo
  • Orencia
  • Reyataz
  • Sprycel
  • Sunvepra
  • Vepesid
  • Yervoy

Bristol-Myers Squibb invests in research and development in the Australian medicine industry. 

Learn more about our Company Reports

IBISWorld Company Profile Reports

Company profile reports provide key information on the Top 2000 earning companies in Australia. Reports include a written description of a company, its history, brands and products, contact details and key personnel, operating and legal structure, financial data, industries of involvement and business service providers.

Sample Data

This Company Has Operations in the Following Industries:

Pharmaceuticals Wholesaling in Australia

Table of Contents

Company Details
Key Personnel
Growth & Ratios
Service Providers

Looking for our Industry reports?

Assess your competitors with powerful business tools that provide strategic insights and analysis on over 600 Australian industries.

Contact Us

Want to speak to a representative? Call us.